146 related articles for article (PubMed ID: 22624424)
1. [Differences in depression severity and frequency of relapses in opiate addicts treated with methadone or opiate blocker after detoxification].
Jovanović T; Lazarević D; Nikolić G
Vojnosanit Pregl; 2012 Apr; 69(4):326-32. PubMed ID: 22624424
[TBL] [Abstract][Full Text] [Related]
2. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
Hensel M; Kox WJ
Acta Anaesthesiol Scand; 2000 Mar; 44(3):326-33. PubMed ID: 10714849
[TBL] [Abstract][Full Text] [Related]
3. Opiate addiction and plasma beta-endorphin-like immunoreactivity: methadone maintained, recently detoxified and early naltrexone treated ex-addicts.
Cushman P; Morris D; Adams M; Dewey W
Alcohol Drug Res; 1987; 7(5-6):533-40. PubMed ID: 2956960
[TBL] [Abstract][Full Text] [Related]
4. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
Wright NM; Sheard L; Adams CE; Rushforth BJ; Harrison W; Bound N; Hart R; Tompkins CN
Br J Gen Pract; 2011 Dec; 61(593):e772-80. PubMed ID: 22137413
[TBL] [Abstract][Full Text] [Related]
5. Use of very low-dose naltrexone during opiate detoxification.
Mannelli P; Gottheil E; Buonanno A; De Risio S
J Addict Dis; 2003; 22(2):63-70. PubMed ID: 12703669
[TBL] [Abstract][Full Text] [Related]
6. [Limited role of naltrexone in the treatment of opiate addiction].
van Brussel GH
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
[TBL] [Abstract][Full Text] [Related]
7. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Gold MS
Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
[TBL] [Abstract][Full Text] [Related]
8. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
[TBL] [Abstract][Full Text] [Related]
9. Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients.
Mysels DJ; Vosburg SK; Benga I; Levin FR; Sullivan MA
J Opioid Manag; 2011; 7(1):47-53. PubMed ID: 21434584
[TBL] [Abstract][Full Text] [Related]
10. Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.
Rabinowitz J; Cohen H; Tarrasch R; Kotler M
Drug Alcohol Depend; 1997 Aug; 47(2):77-86. PubMed ID: 9298329
[TBL] [Abstract][Full Text] [Related]
11. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.
Bochud Tornay C; Favrat B; Monnat M; Daeppen JB; Schnyder C; Bertschy G; Besson J
Drug Alcohol Depend; 2003 Apr; 69(3):283-8. PubMed ID: 12633914
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
Foster J; Brewer C; Steele T
Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
[TBL] [Abstract][Full Text] [Related]
13. Voucher-based reinforcement of opiate abstinence during methadone detoxification.
Robles E; Stitzer ML; Strain EC; Bigelow GE; Silverman K
Drug Alcohol Depend; 2002 Jan; 65(2):179-89. PubMed ID: 11772479
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic treatment with methadone and naltrexone on sleep in addicts.
Staedt J; Wassmuth F; Stoppe G; Hajak G; Rodenbeck A; Poser W; Rüther E
Eur Arch Psychiatry Clin Neurosci; 1996; 246(6):305-9. PubMed ID: 8908412
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with relapse among opiate addicts in an out-patient detoxification programme.
Unnithan S; Gossop M; Strang J
Br J Psychiatry; 1992 Nov; 161():654-7. PubMed ID: 1422615
[TBL] [Abstract][Full Text] [Related]
16. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China.
Hser YI; Li J; Jiang H; Zhang R; Du J; Zhang C; Zhang B; Evans E; Wu F; Chang YJ; Peng C; Huang D; Stitzer ML; Roll J; Zhao M
Addiction; 2011 Oct; 106(10):1801-9. PubMed ID: 21793958
[TBL] [Abstract][Full Text] [Related]
17. Opiate detoxification protocols. A clinical manual.
Fishbain DA; Rosomoff HL; Cutler R
Ann Clin Psychiatry; 1993 Mar; 5(1):53-65. PubMed ID: 8394176
[TBL] [Abstract][Full Text] [Related]
18. Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice.
Merlo LJ; Greene WM; Pomm R
J Addict Med; 2011 Dec; 5(4):279-83. PubMed ID: 22107877
[TBL] [Abstract][Full Text] [Related]
19. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
[TBL] [Abstract][Full Text] [Related]
20. The rationale for naltrexone therapy as an alternative to methadone treatment for opiate addiction.
Simon DL
Conn Med; 1996 Nov; 60(11):683-5. PubMed ID: 8979434
[No Abstract] [Full Text] [Related]
[Next] [New Search]
